JSM 2004 - Toronto

JSM Activity #156

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
156 Mon, 8/9/04, 2:00 PM - 3:50 PM TCC-714 A
Incomplete Data - Contributed - Papers
Biopharmaceutical Section
Chair(s): Lifen Zhou, Amgen, Inc.
     2:05 PM   Application of Multiple Imputation in Calculating Propensity Scores in Observational Studies — Brenda J. Crowe, Eli Lilly and Company; Ouhong Wang, Eli Lilly and Company
     2:20 PM   Impute Missing Values below Precision Level — Ying Wan, Merck & Co., Inc.; Cong Chen, Merck & Co., Inc.
     2:35 PM   Estimating Relative Potency in Direct Assays Containing Nonresponders — Daniel C. Bonzo, Serono, Inc.; Eugene Laska, Nathan S. Kline Institute for Psychiatric Research
     2:50 PM   Modeling LOCF Analysis of Continuous Endpoints in Clinical Trials — Vijay Chauhan, NJ Biostatistics Inc.
     3:05 PM   Comparison of Methods of Missing-data Imputation in Analysis of Two Phase III Trials Treating HIV1 Infection — Les Huson, F. Hoffman La Roche; Jain Chung, F. Hoffman La Roche; Miklos Salgo, F. Hoffman La Roche
     3:20 PM   Generally Applicable Modes of Analyses for Incomplete Binary Longitudinal Clinical Trial Data — Ivy Jansen, Limburgs Universitair Centrum; Caroline Beunckens, Limburgs Universitair Centrum; Geert Molenberghs, Limburgs Universitair Centrum; Geert Verbeke, Katholieke Universiteit Leuven; Craig H. Mallinckrodt, Eli Lilly and Company
     3:35 PM   Modified Intention-to-treat Analysis in Clinical Trials — Chunqin Deng, PPD Development, Inc.
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004